Zhou et al. [66] reveal that reduced CBS expression in HCC is associated with poor prognosis in HCC, and downregulation of CBS activates the IL-6/STAT3 signaling pathway, which directly inhibits apoptosis and induces infiltration of Treg cells in the tumor microenvironment. Here, IL6 is linked to hepatocellular carcinoma.